期刊文献+

柯萨奇病毒A组16型连续四年分离株基因差异研究

Research on the genetic diversity of coxsackievirus A16 isolates in 4 consecutive years
原文传递
导出
摘要 目的了解同一地区不同年份CA16基因变异状况。方法在同一地区用同一方法分离CA16;随机抽取第一代细胞分离到的病毒株,测定VPl区基因序列,应用DNAstar和DNAman分子生物学软件对VPl基因进行分析比较。结果在2008年一2011年从104份标本中分离到47株CA16,病毒分离阳性率为45.2%;4年来,8株CA16核苷酸同源性为90.3%-100.0%,其中2010年分离的二株病毒核苷酸同源性为90.3%;8株CA16氨基酸同源性为97.9%-100.0%。结论由于在同一地区不同时间分离的CA16基因存在较大差异,因此选择CA16疫苗株时,应进行各种基因型及同一基因亚型中氨基酸变异较大毒株的交叉保护试验。 Objective To study the variation of CA16 gene during different years in one area. Methods CA16 was isolated from HFMD patients with the same method in the same area ; Then 8 viral isolates of the first - generation cell were randomly se- lected to determine the genetic sequence of VP1 region. DNAstar and DNAman were employed to analyze and compare theVP1 gene of the 8 isolates. Results Forty - seven CA16 strains were isolated from 104 specimens between 2008 and 2011, the posi- tive rate of virus isolation was 45.2%. In the 4 consecutive years, the nucleotide homology of 8 CA16 strains was between 90.3% and 100.0% , that of 2 CA16 isolates in 2010 was 90.3%, while the amino acid homology of the 8 CA16 iso]ates was between 97.9% and 100.0%. Conclusion As a result of the big diversity of CA16 gene at different times in one area, the cross -protection trial should be done in viral strains concerning different genotypes and big amino acid variation in the same subgenotype when selecting CA16 vaccine strain.
出处 《中国卫生检验杂志》 北大核心 2014年第3期316-318,共3页 Chinese Journal of Health Laboratory Technology
关键词 柯萨奇病毒A组16型 同一地区不同年份 VP1区基因序列 疫苗株选择 Coxsackievirus A16 Different years in one area Genetic sequence of VP1 region Vaccine strain selection
  • 相关文献

参考文献6

二级参考文献41

  • 1严菊英,卢亦愚,徐昌平,史雯,龚黎明,葛琼.肠道病毒TaqMan荧光定量RT-PCR法快速检测[J].中国公共卫生,2007,23(7):818-820. 被引量:31
  • 2Komatsu H,Shimizu Y,Takeuchi Y,et al.Outbreak of severe neurologic involvement associated with enterovirus 71 infection.Pediatr Neurol,1999,20(1):17-23.
  • 3Li L,He Y,Yang H,et al.Genetic characteristics of human entorovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen,People's Republic of China.J Clin Microbiol,2005,43 (8):3835-3839.
  • 4Chang LY,Lin TY,Huang YC,et al.Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic,1998.Pediatr Infect Dis J,1999,18(12):1092-1096.
  • 5Hosoya M,Kawasaki Y,Sato M,et al.Genetic diversity of coxsackievirus A16 associated with hand,foot,and mouth disease epidemics in Japan from 1983 to 2003.J Clin Microbiol,2007,45(1):112-120.
  • 6Perera D,Yusof MA,Podin Y,et al.Molecular phylogeny of modem coxsackievirus A16.Arch Virol,2007,152 (6):1201-1208.
  • 7Iwai M,Masaki A,Hasegawa S,et al.Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand,foot,and mouth disease patients in Toyama,Japan between 1981 and 2007.Jpn J Infect Dis,2009,62(4):254-259.
  • 8Yang F,Ren L,Xiong Z,et al.Enterovirus 71 outbreak in the People's Republic of China in 2008.J Clin Microbiol,2009,47(7):2351-2352.
  • 9World Health Organization.Polio laboratory manual.4th ed.Document World Health Oraganization/IVB/04.10.Geneva,Switzerland,2004.
  • 10Zhang Y,Wang D,Yan D,et al.Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand,foot,and mouth disease in China.J Clin Microbiol,DOI:10.1128/JCM.02338-09.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部